Advocacy intelligence hub — real-time data for patient organizations
Guilherme Sant'Anna, MD — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
XGEVA
(denosumab)Orphan drugstandardAmgen, Inc.
RANK Ligand Inhibitor [EPC]
12.1 Mechanism of Action Xgeva binds to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of osteoclasts, ...
Guilherme Sant'Anna, MD, PhD
The Research institute of the McGill University Health Centre
Francesco Cresi, MD, PhD
University of Turin, Italy
Thomas Riva, M.D.
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital,
Alexander Fuchs, M.D.
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital,
Elisabeth Salisbury
University of Massachusetts, Worcester
Adeline Gerst
University Hospital, Clermont-Ferrand